Meta Robotics Achieves Double-Digit Growth in 2025 Performance... Accelerates Global Expansion

Meta Robotics, a global total healthcare platform company, announced that last year it recorded sales of 147.3 billion KRW, operating profit of 21.2 billion KRW, and EBITDA of 25.1 billion KRW. Compared to the previous year, this represents a 13% increase in sales and a 22% increase in operating profit.

A Meta Robotics representative stated, "This performance growth is the result of both the growth of major affiliates and the expansion of overseas business. There was a significant increase in medical device exports, and the online platform business also achieved stable growth, leading to simultaneous sales growth and improved profitability."

Affiliate Meta Pharm posted strong growth, with sales up 69% and operating profit up 92% year-on-year, continuing its growth streak for the fifth consecutive year. Subsidiary Ezen Implant was awarded the '10 Million Dollar Export Tower' in December last year, driven by increased overseas sales of dental implants. Demand is also rising both domestically and internationally for its self-developed and produced 'Miniting' PDO threads for lifting and the 'Meta Hair' medical device for hair transplantation.

Another affiliate, Tech Labs, saw increased sales thanks to its healthcare marketing business and the growth of 'Jeomsin,' the leading fortune-telling tech platform in Korea. In particular, the fortune-based reward service 'Luckyverse' is rapidly expanding its user base by being featured on major financial and lifestyle platforms such as TOSS, Shinhan SOL Pay, and Hana Money.

This year, Meta Robotics plans to accelerate its global expansion and upgrade its business portfolio. In July last year, the company signed a strategic memorandum of understanding (MOU) with YAS Healthcare, under DAS Holding based in Abu Dhabi, United Arab Emirates, and began its entry into the Middle East and North Africa (MENA) market. Through this, the company plans to open a K-Beauty Medical Center in Business Bay, the central commercial district of Dubai, within the year.

Meta Pharm is considering strategic mergers and acquisitions (M&A) in high-value medical device sectors such as fillers and botulinum toxin (botox), and is in discussions with several promising companies. The company aims to strengthen its global competitiveness and accelerate growth by expanding its product portfolio.

Tech Labs will continue to expand its platform centered on Luckyverse and will seek to diversify its revenue model and grow traffic by expanding partnerships with major super apps. In the long term, the company plans to leverage accumulated user data from its platform to expand into healthcare services and AI-based personalized services.

A Meta Robotics representative said, "The K-Beauty industry is rapidly shifting from a cosmetics-centered market to a high-value service market based on medical procedures. By combining our medical device manufacturing capabilities, digital platform technology, global network, and management consulting experience across various medical fields including dermatology, plastic surgery, dentistry, and Korean medicine clinics, we aim to become a total global K-Beauty medical platform company that achieves both scalability and profitability."

This content was produced with the assistance of AI translation services.